Mineralys Therapeutics
MLYS
#5780
Rank
C$1.73 B
Marketcap
C$19.59
Share price
-3.53%
Change (1 day)
-66.82%
Change (1 year)

EPS for Mineralys Therapeutics (MLYS)

EPS in 2026 (TTM): C-$6.16

According to Mineralys Therapeutics's latest financial reports the company's current EPS (TTM) is C-$6.25. In 2025 the company made an earnings per share (EPS) of C-$3.40 an increase over its 2024 EPS that were of C-$5.22.

EPS history for Mineralys Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$6.1681.26%
2025C-$3.40-34.89%
2024C-$5.22
2022C-$6.07